2013 BRFSS Asthma Call-Back Survey Prevalence Tables

TABLE 11b. Estimated percent reporting a medical diagnosis of depression for active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013

State/Territory Active Inactive
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 138 48.6 8.8 (31.4 – 65.8) 27 N/A N/A (N/A – N/A)
Arizona 106 N/A N/A (N/A – N/A) 27 N/A N/A (N/A – N/A)
California 183 41.2 6.0 (29.4 – 53.0) 80 N/A N/A (N/A – N/A)
Connecticut 231 23.7 4.2 (15.5 – 31.9) 67 N/A N/A (N/A – N/A)
Florida 769 45.4 5.1 (35.4 – 55.4) 220 36.2 8.3 (19.9 – 52.5)
Georgia 132 30.5 6.5 (17.8 – 43.2) 53 N/A N/A (N/A – N/A)
Hawaii 110 N/A N/A (N/A – N/A) 68 N/A N/A (N/A – N/A)
Indiana 338 49.2 5.2 (39.0 – 59.4) 83 N/A N/A (N/A – N/A)
Iowa 213 33.8 6.2 (21.6 – 46.0) 67 N/A N/A (N/A – N/A)
Kansas 656 38.9 3.7 (31.6 – 46.2) 151 25.9 7.0 (12.2 – 39.6)
Kentucky 365 48.9 4.9 (39.3 – 58.5) 45 N/A N/A (N/A – N/A)
Louisiana 143 43.2 9.4 (24.8 – 61.6) 32 N/A N/A (N/A – N/A)
Maine 240 36.4 5.0 (26.6 – 46.2) 46 N/A N/A (N/A – N/A)
Maryland 248 42.1 5.7 (30.9 – 53.3) 53 N/A N/A (N/A – N/A)
Massachusetts 148 33.1 8.4 (16.6 – 49.6) 33 N/A N/A (N/A – N/A)
Michigan 494 43.8 4.2 (35.6 – 52.0) 83 N/A N/A (N/A – N/A)
Mississippi 216 46.2 8.0 (30.5 – 61.9) 52 N/A N/A (N/A – N/A)
Missouri 220 40.9 5.9 (29.3 – 52.5) 54 N/A N/A (N/A – N/A)
Montana 279 49.3 8.1 (33.4 – 65.2) 66 N/A N/A (N/A – N/A)
Nebraska 287 38.7 9.2 (20.7 – 56.7) 71 N/A N/A (N/A – N/A)
Nevada 113 42.6 9.8 (23.4 – 61.8) 38 N/A N/A (N/A – N/A)
New Hampshire 228 46.9 6.5 (34.2 – 59.6) 56 34.7 9.7 (15.7 – 53.7)
New Jersey 283 30.4 5.7 (19.2 – 41.6) 49 N/A N/A (N/A – N/A)
New Mexico 238 36.1 5.6 (25.1 – 47.1) 57 N/A N/A (N/A – N/A)
New York 112 23.8 6.6 (10.9 – 36.7) 34 N/A N/A (N/A – N/A)
North Carolina 122 44.8 7.6 (29.9 – 59.7) 22 N/A N/A (N/A – N/A)
Ohio 258 48.6 5.9 (37.0 – 60.2) 57 N/A N/A (N/A – N/A)
Oklahoma 227 30.0 4.9 (20.4 – 39.6) 72 N/A N/A (N/A – N/A)
Oregon 184 54.1 7.4 (39.6 – 68.6) 49 N/A N/A (N/A – N/A)
Pennsylvania 267 41.1 5.7 (29.9 – 52.3) 69 N/A N/A (N/A – N/A)
Rhode Island 205 36.3 6.1 (24.3 – 48.3) 31 54.8 11.5 (32.3 – 77.3)
Texas 233 35.8 7.0 (22.1 – 49.5) 68 N/A N/A (N/A – N/A)
Utah 326 43.1 6.0 (31.3 – 54.9) 112 35.7 7.8 (20.4 – 51.0)
Vermont 200 34.6 6.0 (22.8 – 46.4) 61 N/A N/A (N/A – N/A)
Washington 296 38.1 5.4 (27.5 – 48.7) 90 46.5 12.2 (22.6 – 70.4)
West Virginia 124 50.3 6.1 (38.3 – 62.3) 21 N/A N/A (N/A – N/A)
Wisconsin 191 47.4 8.8 (30.2 – 64.6) 38 N/A N/A (N/A – N/A)
Puerto Rico 246 33.1 4.9 (23.5 – 42.7) 65 35.2 9.7 (16.2 – 54.2)
38 state total 9,369 39.3 1.4 (36.6 – 42.0) 2,367 25.2 2.5 (20.3 – 30.1)
Median   41.2       35.7    
Range   23.7-54.1       25.9-54.8    

1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

3 Aged ≥ 18 years

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30